Year |
Citation |
Score |
2010 |
Simon ID, van Rooijen N, Rose JK. Vesicular stomatitis virus genomic RNA persists in vivo in the absence of viral replication. Journal of Virology. 84: 3280-6. PMID 20032173 DOI: 10.1128/Jvi.02052-09 |
0.618 |
|
2010 |
Van Rompay KK, Abel K, Earl P, Kozlowski PA, Easlick J, Moore J, Buonocore-Buzzelli L, Schmidt KA, Wilson RL, Simon I, Moss B, Rose N, Rose J, Marthas ML. Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV. Vaccine. 28: 1481-92. PMID 19995539 DOI: 10.1016/J.Vaccine.2009.11.061 |
0.69 |
|
2010 |
Wollmann G, Rogulin V, Simon I, Rose JK, van den Pol AN. Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells. Journal of Virology. 84: 1563-73. PMID 19906910 DOI: 10.1128/Jvi.02040-09 |
0.53 |
|
2009 |
van den Pol AN, Ozduman K, Wollmann G, Ho WS, Simon I, Yao Y, Rose JK, Ghosh P. Viral strategies for studying the brain, including a replication-restricted self-amplifying delta-G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi-like expression. The Journal of Comparative Neurology. 516: 456-81. PMID 19672982 DOI: 10.1002/Cne.22131 |
0.583 |
|
2008 |
Kapadia SU, Simon ID, Rose JK. SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector. Virology. 376: 165-72. PMID 18396306 DOI: 10.1016/J.Virol.2008.03.002 |
0.506 |
|
2007 |
Simon ID, Publicover J, Rose JK. Replication and propagation of attenuated vesicular stomatitis virus vectors in vivo: vector spread correlates with induction of immune responses and persistence of genomic RNA. Journal of Virology. 81: 2078-82. PMID 17151110 DOI: 10.1128/Jvi.02525-06 |
0.617 |
|
Show low-probability matches. |